![](/img/cover-not-exists.png)
JAK Inhibition: The Most Promising Agents in the IBD Pipeline?
Fernández-Clotet, Agnès, Castro-Poceiro, Jesús, Panés, JuliánVolume:
25
Journal:
Current Pharmaceutical Design
DOI:
10.2174/1381612825666190405141410
Date:
May, 2019
File:
PDF, 4.46 MB
2019